Trade Deal Looking Worse For Pharma As Details Emerge
This article was originally published in PharmAsia News
Executive Summary
As details gradually emerge, it is becoming clear that the Trans-Pacific Partnership excludes patent linkage and evergreening provisions that the pharma industry had sought in addition to 12 years of biologics data exclusivity, which got knocked back to an eight-year effective period.